Vietnam-focused private equity firm Mekong Capital said on Monday it has successfully divested the entire 24.99 per cent holding in pharmaceutical major Traphaco JSC for a total consideration of more than $64.5 million.
Continue reading this premium story with a subscription to DealStreetAsia.
SubscribeAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com